Selway Asset Management’s Eli Lilly LLY Stock Holding History

Selway Asset Management’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-200	Closed	-$65K	–	116
2022 Q3	$65K	Buy	+200	New	+$63.4K	0.04%	89

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Selway Asset Management's LLY Position: Q4 2022 in Review

Selway Asset Management sold out of Eli Lilly (LLY) in Q4 2022, closing a stake of 200 shares — an estimated $65K sold.

Selway Asset Management first reported a position in LLY in Q3 2022 and held it in 1 quarter. The position peaked at $65K in Q3 2022. 2,672 funds tracked by Wall St. Rank hold LLY as of Q4 2022.

Selway Asset Management reported no remaining Eli Lilly position as of Q4 2022 after selling out during the quarter.
Selway Asset Management sold 200 Eli Lilly shares in Q4 2022, an estimated $65K.
Selway Asset Management first reported a position in Eli Lilly in Q3 2022 and held it in 1 quarter.
Selway Asset Management's Eli Lilly position peaked at $65K in Q3 2022.
2,672 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2022.

Based on Selway Asset Management's 13F filing for Q4 2022, filed 17 Feb 2023.